You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
國內疫情多處散點發生促新冠檢測板塊繼續走強,九安醫療、博拓生物漲停
格隆匯1月12日丨隨着國內疫情多處散點發生,新冠檢測板塊繼續走強。科創板博拓生物漲停,九安醫療連續第二日漲停創歷史新高,亞輝龍、九強生物、美康生物、東方生物、熱景生物、邁克生物等集體上漲。消息面上,除了國外疫情高發助推新冠檢測試劑價格暴漲外,近日新冠疫情在國內包括河南、天津、陝西、深圳等多省份、城市出現散點發生,也使得新冠檢測試劑需求量大增。國家衞健委數據顯示,1月11日0—24時,31個省(自治區、直轄市)和新疆生產建設兵團報吿新增確診病例221例。其中境外輸入病例55例,本土病例166例。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account